Table of contents

Extended reports

• Contribution of tumour necrosis factor α and interleukin (IL) 1β to IL6 production, NF-κB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors (24 February, 2005)

  G Chevrel, C Granet, P Miossec
• Synovial tissue inflammation in early and late osteoarthritis (24 February, 2005)

  M J Benito, D J Veale, O FitzGerald, W B van den Berg, B Bresnihan
• Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis (11 February, 2005)

  O Vignaux, Y Allanore, C Meune, O Pascal, D Duboc, S Weber, P Legmann, A Kahan
• Treatment continuation in patients receiving biological agents or conventional DMARD therapy (11 February, 2005)

  A Zink, J Listing, S Kary, P Ramlau, M Stoyanova-Scholz, K Babinsky, U von Hinueber, E Gromnica-Ihle, S Wassenberg, C Antoni, P Herzer, J Kekow, M Schneider, R Rau
• Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography (13 January, 2005)

  B J Ejbjerg, E Narvestad, S Jacobsen, H S Thomsen, M Østergaard
• A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs (10 March, 2005)

  E H Choy, G H Kingsley, B Khoshaba, N Pipitone, D L Scott
• Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial (13 April, 2005)

  J Fransen, H Bernelot Moens, I Speyer, P L C M van Riel
• Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis (11 February, 2005)

  J J C S Veldhuijzen van Zanten, C Ring, D Carroll, G D Kitas
• Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept (18 March, 2005)

  M Rudwaleit, X Baraliakos, J Listing, J Brandt, J Sieper, J Braun
• Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis

  (24 February, 2005)

  A Barton, J Bowes, S Eyre, D Symmons, J Worthington, A Silman
• Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies (10 March, 2005)

  T Cantaert, P Coucke, L De Rycke, E M Veys, F De Keyser, D Baeten
• Real world experience with antiphospholipid antibody tests: how stable are results over time? (24 February, 2005)

  D Erkan, W J M Derksen, V Kaplan, L Sammaritano, S S Pierangeli, R Roubey, M D Lockshin
• Lamivudine is not effective in primary Sjögren’s syndrome (11 February, 2005)

  B Gescuk, A J Wu, J P Whitcher, T E Daniels, S Lund, K Fye, J C Davis
• Course and prognosis of elbow complaints: a cohort study in general practice (11 February, 2005)

  S D M Bot, J M van der Waal, C B Terwee, D A W M van der Windt, L M Bouter, J Dekker
• A re-examination of the whiplash associated disorders (WAD) as a systemic illness (24 February, 2005)

  R Ferrari, A S Russell, L J Carroll, J D Cassidy